Načítá se...
Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
BACKGROUND: Integrase strand transfer inhibitors (INSTIs) are the class of antiretroviral (ARV) drugs most recently approved by the FDA for the treatment of HIV-1 infections. INSTIs block the strand transfer reaction catalyzed by HIV-1 integrase (IN) and have been shown to potently inhibit infection...
Uloženo v:
| Vydáno v: | Retrovirology |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5956922/ https://ncbi.nlm.nih.gov/pubmed/29769116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12977-018-0420-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|